Skip to main content
RxCopaysGet started

Acute Myeloid Leukemia

Rare

Cancer

Acute Myeloid Leukemia is treated with 20 medications in our database, including Idamycin PFS, ONUREG, RYDAPT, mitoXANTRONE, Cytarabine, and 15 more. 17 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Pfizer, Bristol Myers Squibb, Novartis, EMD Serono, Daiichi Sankyo and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Acute Myeloid Leukemia treatment below.

What help exists for Acute Myeloid Leukemia

27

drugs indexed

21

with copay cards

21

with patient assistance

21

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Acute Myeloid Leukemia

27 total

🎟 = copay card · 💙 = patient assistance program

Prior authorization patterns for Acute Myeloid Leukemia drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

Showing 10 of 25 PA rules for Acute Myeloid Leukemia drugs. View individual drug pages for complete PA detail.

Grants for Acute Myeloid Leukemia patients

30 total · 21 open

Acute Myeloid Leukemia is a rare disease — more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare →